BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

9408

543524

RAINBOW

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

RAINBOW CHILDRENS MED LTD performance

Today’s low

Today’s high

₹ 1352.50 ₹ 1417.80
₹ 1381.70

52 week low

52 week high

₹ 1079.10 ₹ 1709.60
₹ 1381.70

Open Price

₹ 1352.60

Prev. Close

₹ 1357.30

Volume (Shares)

348281.00

Total traded value

₹ 4812.19

Upper Circuit

₹ 1628.70

Lower Circuit

₹ 1085.90

info

RAINBOW CHILDRENS MED LTD Share Price Update

As of the latest trading session, RAINBOW CHILDRENS MED LTD share price is currently at ₹ 1372, which is up by ₹ 14.69 from its previous closing. Today, the stock has fluctuated between ₹ 1352.50 and ₹ 1417.80. Over the past year, RAINBOW CHILDRENS MED LTD has achieved a return of -0.35 %. In the last month alone, the return has been -1.01 %. Read More...

RAINBOW CHILDRENS MED LTD fundamentals


  • Market cap (Cr)

    13,926.03

  • P/E Ratio (TTM)

    60.11

  • Beta

    0.41

  • Book Value / share

    134.65

  • Return on equity

    18.11%

  • EPS (TTM)

    22.99

  • Dividend yield

    0.22%

  • Net profit/quarter (Cr)

    66.98

info icon alternate text
  • Market cap (Cr)

    13,946.33

  • P/E Ratio (TTM)

    60.11

  • Beta

    0.42

  • Book Value / share

    134.65

  • Return on equity

    18.11%

  • EPS (TTM)

    22.99

  • Dividend yield

    0.22%

  • Net profit/quarter (Cr)

    66.98

info icon alternate text

RAINBOW CHILDRENS MED LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 381.57
Operating Expense 302.30
Net Profit 66.98
Net Profit Margin (%) 17.55
Earnings Per Share (EPS) 6.60
EBITDA 143.00
Effective Tax Rate (%) 27.29
Particulars SEP 2024 (Values in Cr)
Revenue 403.93
Operating Expense 311.05
Net Profit 77.34
Net Profit Margin (%) 19.14
Earnings Per Share (EPS) 7.62
EBITDA 154.20
Effective Tax Rate (%) 25.33
Particulars JUN 2024 (Values in Cr)
Revenue 315.02
Operating Expense 274.88
Net Profit 38.73
Net Profit Margin (%) 12.29
Earnings Per Share (EPS) 3.82
EBITDA 101.51
Effective Tax Rate (%) 24.98
Particulars MAR 2024 (Values in Cr)
Revenue 325.76
Operating Expense 269.57
Net Profit 50.44
Net Profit Margin (%) 15.48
Earnings Per Share (EPS) 4.97
EBITDA 115.10
Effective Tax Rate (%) 26.29
Particulars DEC 2023 (Values in Cr)
Revenue 321.79
Operating Expense 247.49
Net Profit 61.14
Net Profit Margin (%) 18.99
Earnings Per Share (EPS) 6.03
EBITDA 122.00
Effective Tax Rate (%) 25.92
Particulars MAR 2024 (Values in Cr)
Revenue 1236.56
Operating Expense 984.30
Net Profit 214.89
Net Profit Margin (%) 17.37
Earnings Per Share (EPS) 21.17
EBITDA 450.44
Effective Tax Rate (%) 25.70
Particulars MAR 2023 (Values in Cr)
Revenue 1113.99
Operating Expense 867.76
Net Profit 205.89
Net Profit Margin (%) 18.48
Earnings Per Share (EPS) 20.40
EBITDA 408.62
Effective Tax Rate (%) 24.53
Particulars MAR 2022 (Values in Cr)
Revenue 924.60
Operating Expense 755.68
Net Profit 142.29
Net Profit Margin (%) 15.38
Earnings Per Share (EPS) 15.18
EBITDA 316.74
Effective Tax Rate (%) 25.00
Particulars MAR 2021 (Values in Cr)
Revenue 614.45
Operating Expense 560.51
Net Profit 49.41
Net Profit Margin (%) 8.04
Earnings Per Share (EPS) 11.24
EBITDA 175.48
Effective Tax Rate (%) 25.01
Particulars MAR 2020 (Values in Cr)
Revenue 695.11
Operating Expense 597.88
Net Profit 70.88
Net Profit Margin (%) 10.19
Earnings Per Share (EPS) 15.94
EBITDA 217.09
Effective Tax Rate (%) 35.06
Particulars MAR 2024 (Values in Cr)
Book Value / Share 124.03
ROE % 18.83
ROCE % 19.48
Total Debt to Total Equity 0.58
EBITDA Margin 36.20
Particulars MAR 2023 (Values in Cr)
Book Value / Share 104.42
ROE % 25.72
ROCE % 24.07
Total Debt to Total Equity 0.69
EBITDA Margin 36.68
Particulars MAR 2022 (Values in Cr)
Book Value / Share 62.93
ROE % 27.00
ROCE % 22.55
Total Debt to Total Equity 1.05
EBITDA Margin 33.56
Particulars MAR 2021 (Values in Cr)
Book Value / Share 99.05
ROE % 9.54
ROCE % 10.90
Total Debt to Total Equity 1.18
EBITDA Margin 26.98
Particulars MAR 2020 (Values in Cr)
Book Value / Share 89.73
ROE % 14.47
ROCE % 16.22
Total Debt to Total Equity 1.23
EBITDA Margin 29.33
Particulars MAR 2024 (Values in Cr)
Book Value / Share 126.62
ROE % 18.11
ROCE % 19.04
Total Debt to Total Equity 0.54
EBITDA Margin 36.69
Particulars MAR 2023 (Values in Cr)
Book Value / Share 107.23
ROE % 24.03
ROCE % 23.23
Total Debt to Total Equity 0.63
EBITDA Margin 36.95
Particulars MAR 2022 (Values in Cr)
Book Value / Share 66.49
ROE % 26.10
ROCE % 22.51
Total Debt to Total Equity 0.93
EBITDA Margin 34.56
Particulars MAR 2021 (Values in Cr)
Book Value / Share 105.78
ROE % 11.23
ROCE % 11.75
Total Debt to Total Equity 1.06
EBITDA Margin 28.91
Particulars MAR 2020 (Values in Cr)
Book Value / Share 94.33
ROE % 17.17
ROCE % 22.69
Total Debt to Total Equity 0.62
EBITDA Margin 31.74
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 10.12
Total Assets 2170.39
Total Liabilities 2170.39
Total Equity 1264.92
Share Outstanding 101501687
Price to Book Ratio 10.25
Return on Assets (%) 9.99
Return on Capital (%) 17.16
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 47.06
Total Assets 1770.72
Total Liabilities 1770.72
Total Equity 1064.91
Share Outstanding 101501687
Price to Book Ratio 6.81
Return on Assets (%) 11.90
Return on Capital (%) 19.8
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 185.21
Total Assets 1295.74
Total Liabilities 1295.74
Total Equity 606.26
Share Outstanding 94053928
Price to Book Ratio 0.00
Return on Assets (%) 10.67
Return on Capital (%) 21.34
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 94.67
Total Assets 1081.26
Total Liabilities 1081.26
Total Equity 448.37
Share Outstanding 43958924
Price to Book Ratio 0.00
Return on Assets (%) 3.70
Return on Capital (%) 8.06
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 97.24
Total Assets 1019.23
Total Liabilities 1019.23
Total Equity 409.31
Share Outstanding 43958924
Price to Book Ratio 0.00
Return on Assets (%) 5.46
Return on Capital (%) 11.93
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 7.49
Total Assets 2150.43
Total Liabilities 2150.43
Total Equity 1285.25
Share Outstanding 101501687
Price to Book Ratio 10.25
Return on Assets (%) 9.99
Return on Capital (%) 16.72
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 35.59
Total Assets 1758.75
Total Liabilities 1758.75
Total Equity 1088.38
Share Outstanding 101501687
Price to Book Ratio 6.81
Return on Assets (%) 11.70
Return on Capital (%) 18.92
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 175.14
Total Assets 1285.36
Total Liabilities 1285.36
Total Equity 636.29
Share Outstanding 94053928
Price to Book Ratio 0.00
Return on Assets (%) 11.07
Return on Capital (%) 20.99
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 84.75
Total Assets 1069.83
Total Liabilities 1069.83
Total Equity 475.93
Share Outstanding 43958924
Price to Book Ratio 0.00
Return on Assets (%) 4.61
Return on Capital (%) 9.43
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 94.32
Total Assets 1011.85
Total Liabilities 1011.85
Total Equity 425.62
Share Outstanding 43958924
Price to Book Ratio 0.00
Return on Assets (%) 7.00
Return on Capital (%) 14.9
Particulars MAR 2024 (Values in Cr)
Net Income 294.81
Cash from Operations 410.01
Cash from Investing -226.46
Cash from Financing -101.78
Net change in Cash -6.84
Free Cash Flow 763.59
Particulars MAR 2023 (Values in Cr)
Net Income 281.77
Cash from Operations 409.64
Cash from Investing -465.20
Cash from Financing 143.40
Net change in Cash 6.98
Free Cash Flow 550.94
Particulars MAR 2022 (Values in Cr)
Net Income 187.34
Cash from Operations 286.40
Cash from Investing -175.34
Cash from Financing -44.06
Net change in Cash 4.32
Free Cash Flow 348.62
Particulars MAR 2021 (Values in Cr)
Net Income 55.69
Cash from Operations 169.20
Cash from Investing -82.88
Cash from Financing -60.87
Net change in Cash -1.03
Free Cash Flow 245.30
Particulars MAR 2020 (Values in Cr)
Net Income 93.35
Cash from Operations 190.51
Cash from Investing -117.03
Cash from Financing -51.81
Net change in Cash 1.56
Free Cash Flow 265.02
Particulars MAR 2024 (Values in Cr)
Net Income 289.21
Cash from Operations 392.49
Cash from Investing -213.72
Cash from Financing -96.99
Net change in Cash -4.30
Free Cash Flow 744.58
Particulars MAR 2023 (Values in Cr)
Net Income 272.83
Cash from Operations 393.10
Cash from Investing -460.27
Cash from Financing 147.68
Net change in Cash 2.19
Free Cash Flow 532.79
Particulars MAR 2022 (Values in Cr)
Net Income 189.74
Cash from Operations 276.08
Cash from Investing -169.20
Cash from Financing -41.13
Net change in Cash 3.72
Free Cash Flow 334.60
Particulars MAR 2021 (Values in Cr)
Net Income 65.89
Cash from Operations 168.06
Cash from Investing -86.79
Cash from Financing -56.43
Net change in Cash -1.66
Free Cash Flow 243.50
Particulars MAR 2020 (Values in Cr)
Net Income 109.17
Cash from Operations 197.90
Cash from Investing -122.83
Cash from Financing -54.26
Net change in Cash 1.02
Free Cash Flow 259.84
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6992.60 76.74 13.41 100542.86 5690.80 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 78.74 192.05 4.94 147.57 51.01 / 98.70
SHREE PACETRONIX LTD. 71.00 14.79 1.90 25.56 61.11 / 268.50
TRANSGENE BIOTEK LTD. 3.75 0.00 2.62 28.41 3.22 / 10.84
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6992.60 83.66 12.27 100542.86 5690.80 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 31.25 0.00 -16.74 23.34 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5584.95 29.60 6.27 6109.94 3750.00 / 6400.00

RAINBOW CHILDRENS MED LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1381.70 1.79 redarrow
red-green-graph indicator
15 Bearish
1 Bullish
  • 5 Days 1393.70
  • 26 Days 1408.70
  • 10 Days 1415.10
  • 50 Days 1397.50
  • 12 Days 1418.10
  • 100 Days 1404.00
  • 20 Days 1415.10
  • 200 Days 1382.90
1364.27 PIVOT

First Support

1343.03

First Resistance

1378.53

Second Support

1328.77

Second Resistance

1399.77

Third Support

1307.53

Third Resistance

1414.03

RSI

41.84

ADX

59.75

MACD

13.96

Williams % R

-96.79

Commodity Channel Index (CCI)

-93.45

Date

2025-04-29

Week

71977.00

Same Day

77312.00

Month

132410.00

1 Year

0.42

3 Year

0.44

Over 1 Month

-1.01%

down

Over 1 Year

-0.35%

down

Over 3 Months

-3.15%

down

Over 3 Years

44.46%

down

Over 6 Months

-7.48%

down

Over 5 Years

0.00%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

RAINBOW CHILDRENS MED LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
11.13%
Promoter Holdings
49.85%
FII
23.69%
DII
15.31%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Ramesh Kancharla 3.1517431E7 (31.04%) Shareholding of Promoter and Promoter Group
Chirla Dinesh Kumar Padmarao 6633310.0 (6.53%) Shareholding of Promoter and Promoter Group
Adarsh Kancharla 6110432.0 (6.02%) Shareholding of Promoter and Promoter Group
Ramesh Kancharla (kancharla Family Trust) 5205700.0 (5.13%) Shareholding of Promoter and Promoter Group
Dsp Aggressive Hybrid Fund 4332926.0 (4.27%) Public Shareholding
Franklin Templeton Investment Funds - Franklin Ind 2273129.0 (2.24%) Public Shareholding
Abu Dhabi Investment Authority - Monsoon 2116497.0 (2.08%) Public Shareholding
Axis Mutual Fund Trustee Limited A/c Axis Mutual F 2051013.0 (2.02%) Public Shareholding
Hdfc Life Insurance Company Limited 1506890.0 (1.48%) Public Shareholding
Sbi Nifty Smallcap 250 Index Fund 1345525.0 (1.32%) Public Shareholding
Ashoka Whiteoak Icav - Ashoka Whiteoak India Oppor 1335362.0 (1.31%) Public Shareholding
Devineni Nagalakshmi 1203009.0 (1.18%) Public Shareholding
Podduturu Preetham Kumar 1115106.0 (1.1%) Public Shareholding
Nippon Life India Trustee Ltd-a/c Nippon India Nif 1096897.0 (1.08%) Public Shareholding
Chirla Padmarao Dinesh Kumar (sai Geeta Dinesh Trust) 1040000.0 (1.02%) Shareholding of Promoter and Promoter Group
Ramadhara Naidu K 60000.0 (0.06%) Shareholding of Promoter and Promoter Group
Srinivas Talasila 60000.0 (0.06%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

RAINBOW CHILDRENS MED LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
22 Jun 2023 3.0 Final 22 Jun 2023 Equity shares
07 Sep 2022 2.0 Final 08 Sep 2022 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
23 Jul 2024 3.0 Final 23 Jul 2024 Equity shares
22 Jun 2023 3.0 Final 22 Jun 2023 Equity shares
07 Sep 2022 2.0 Final 08 Sep 2022 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

RAINBOW CHILDRENS MED LTD Share Price

Rainbow Childrens Medicare Limited was originally incorporated as Rainbow Children's Medicare Private Limited' under as a Private Limited Company pursuant to a Certificate of Incorporation dated August 7, 1998, issued by the Registrar of Companies, Hyderabad at Telangana. Subsequently, the Company converted into a Public Limited Company, and name of the Company changed to Rainbow Children's Medicare Limited' vide a fresh Certificate of Incorporation issued by the RoC on November 20, 2021.

The Company is a leading chain of multi-specialty pediatric, and obstetrics & gynecology hospitals in India, operating 16 hospitals and three clinics in six cities, with a total bed capacity of 1,655 beds, five of which are NABH-accredited and three of which have 183 received EDGE certification. The core specialties are Pediatrics and Obstetrics & Gynecology and emergency services. Its Pediatric Services include newborn and pediatric intensive care, pediatric multi-specialty services, pediatric Quaternary care (including multi-organ transplants); whereas, Obstetrics & Gynecology services include normal and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility treatment.

Rainbow has been pivotal in saving thousands of children. Its inpatient specialties for child care includes Neonatology, Pediatric Intensive Care, Neonatal Intensive Care, Neurology, Gastroenterology, Nephrology, Hematology and Oncology, Pediatric Surgery, Cardiology and Nutrition. The Company was founded on a model of full-time, exclusive doctor led, 24/7 pediatric healthcare delivery, and a significant number of doctors have experience with this same model while training in other countries such as the United Kingdom, United States, Canada and Australia. It also established robust patient retrieval services in and around Hyderabad to retrieve neonates and children from nearby districts to the hub hospital in Hyderabad.

Apart from this, the Company follow a doctor engagement model whereby, most of the core specialists work exclusively at hospitals on a full-time retainer basis. This model ensures that most of core specialists are available 24/7 at the hospitals, which is particularly important for children's emergency, neonatal and pediatric intensive care services. Rainbow Children's Hospital and BirthRight by Rainbow is an exclusive woman and child care hospital with a nationwide footprint. Its full-spectrum, consultant-led woman and child care services are driven by 22 years of experience and have transformed the lives of women and children across the cities of Hyderabad, Vijayawada, Bengaluru, Delhi, Chennai, and Visakhapatnam.

In 1999, Dr. Ramesh Kancharla, the founding Promoter of the Company established first pediatric specialty hospital in 1999 with a 50-bed pediatric hospital in Hyderabad, to address the opportunity to provide pediatric healthcare in the City of Hyderabad. The aim was to provide comprehensive neonatal, pediatric intensive care and pediatric sub-specialty services to children. Since then, under the leadership of Dr. Ramesh Kancharla, Founding Promoter, it established reputation as a leader in multi-specialty pediatric services, with strong clinical expertise in managing complex diseases. The Company has also expanded its operations to include obstetrics and gynecology services, whereby it offer comprehensive perinatal services to patients.

In 2005, the Company expanded Banjara Hills Facility to Pediatric Tertiary Care Centres.

In 2007, the Company established Hospital at Vijayawada. It started perinatal services by providing comprehensive perinatal care which was backed by teamwork, round the clock availability of obstetricians, anesthesiologists, neonatologists and maternal intensive care services.

In 2009, the Company established Hospital at Vikrampuri.

In 2010, the Company inaugurated Opening of outpatient clinic at Madhapur. It established IVF hub at Madhapur and hospital at Kondapur.

In 2015, the Company established hospitals at Hydernagar and Marathalli respectively.

In 2016, the Company established Hospitals at Bangalore and Hyderabad.

In 2017, Madhukar Rainbow Hospital at New Delhi commenced operations.

In 2018, the Company established Hospital at Guindy, in Chennai.

During the year 2019, the Company started outpatient and IVF facility at Kondapur. It commenced commenced providing pediatric Quaternary Care Services at Banjara Hills in Hyderabad.

In 2020, the Company established hospitals at Bengaluru and Vizag.

In May 2021, the Company moved from an old facility to a new facility for its hospital at Vikrampuri, in Hyderabad.

During 2021-22, the Company came out with an Initial Public Offering aggregating 29,168,579 Equity Shares, by issuing 51,67,679 Equity Shares through a fresh issue and 24,000,900 Equity Shares through offer for sale. The IPO comprised of raising capital Rs 280 Crore through fresh issue and Rs 1300 crore through offer for sale, which completed in April, 2022 and resulting to this, the Equity Shares of the Company were listed on National Stock Exchange of India Limited (NSE) and BSE Limited effective May 10, 2022.

In 2022, the Company started Organ Transplantation work at its Hyderabad Hub.

In 2023, the Company inaugurated inaugurated a new hospital with 100 beds in the Financial District of Hyderabad, as well as a 55-bed hospital in Sholinganallur (OMR), Chennai. A brownfield spoke hospital with approximately 80 beds was acquired in Sarjapur, Bengaluru in FY23.

Parent organization Indian Private
NSE symbol RAINBOW
Founded 1998
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Rainbow Childrens Medicare Ltd?

Answer Field

The share price of Rainbow Childrens Medicare Ltd for NSE is ₹ 1372 and for BSE is ₹ 1374.

What is the Market Cap of Rainbow Childrens Medicare Ltd?

Answer Field

The market cap of Rainbow Childrens Medicare Ltd for NSE is ₹ 1,39,26.03 Cr. and for BSE is ₹ 1,39,46.33 Cr. as of now.

What is the 52 Week High and Low of Rainbow Childrens Medicare Ltd?

Answer Field

The 52 Week High and Low of Rainbow Childrens Medicare Ltd for NSE is ₹ 1709.60 and ₹ 1079.10 and for BSE is ₹ 1708.50 and ₹ 1079.25.

How to Buy Rainbow Childrens Medicare Ltd share?

Answer Field

You can trade in Rainbow Childrens Medicare Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Rainbow Childrens Medicare Ltd?

Answer Field

The 1 year returns on the stock has been 0.47%.

What is the Current Share Price of Rainbow Childrens Medicare Ltd?

Answer Field

Rainbow Childrens Medicare Ltd share price is for NSE ₹ 1372 & for BSE ₹ 1374 as on Apr 30 2025 03:29 PM.

What is the Market Cap of Rainbow Childrens Medicare Ltd Share?

Answer Field

The market cap of Rainbow Childrens Medicare Ltd for NSE ₹ 1,39,26.03 & for BSE ₹ 1,39,46.33 as on Apr 30 2025 03:29 PM.

What is the P/E Ratio of Rainbow Childrens Medicare Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM the price-to-earnings (PE) ratio for Rainbow Childrens Medicare Ltd share is 60.11.

What is the PB ratio of Rainbow Childrens Medicare Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM, the price-to-book (PB) ratio for Rainbow Childrens Medicare Ltd share is 134.65.

How to Buy Rainbow Childrens Medicare Ltd Share?

Answer Field

You can trade in Rainbow Childrens Medicare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Rainbow Childrens Medicare Ltd Share on Bajaj Broking App?

Answer Field

To buy Rainbow Childrens Medicare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Rainbow Childrens Medicare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|